150 related articles for article (PubMed ID: 17695519)
1. Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners.
Yu L; Shimozato O; Li Q; Kawamura K; Ma G; Namba M; Ogawa T; Kaiho I; Tagawa M
Anticancer Res; 2007; 27(4B):2311-6. PubMed ID: 17695519
[TBL] [Abstract][Full Text] [Related]
2. Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.
Yu L; Takenobu H; Shimozato O; Kawamura K; Nimura Y; Seki N; Uzawa K; Tanzawa H; Shimada H; Ochiai T; Tagawa M
Oncol Rep; 2005 Oct; 14(4):831-5. PubMed ID: 16142339
[TBL] [Abstract][Full Text] [Related]
3. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
4. Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo.
Seki T; Dmitriev I; Suzuki K; Kashentseva E; Takayama K; Rots M; Uil T; Wu H; Wang M; Curiel DT
Gene Ther; 2002 Aug; 9(16):1101-8. PubMed ID: 12140738
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of human CD46 by adenovirus serotype 35 vectors.
Sakurai F; Akitomo K; Kawabata K; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Jun; 14(11):912-9. PubMed ID: 17377598
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus 11p downregulates CD46 early in infection.
Gustafsson DJ; Andersson EK; Hu YL; Marttila M; Lindman K; Strand M; Wang L; Mei YF
Virology; 2010 Sep; 405(2):474-82. PubMed ID: 20638094
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
Toyoda E; Doi R; Kami K; Mori T; Ito D; Koizumi M; Kida A; Nagai K; Ito T; Masui T; Wada M; Tagawa M; Uemoto S
Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
[TBL] [Abstract][Full Text] [Related]
9. An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism.
Glasgow JN; Kremer EJ; Hemminki A; Siegal GP; Douglas JT; Curiel DT
Virology; 2004 Jun; 324(1):103-16. PubMed ID: 15183058
[TBL] [Abstract][Full Text] [Related]
10. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication.
Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL
Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186
[TBL] [Abstract][Full Text] [Related]
11. The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35.
Sakurai F; Murakami S; Kawabata K; Okada N; Yamamoto A; Seya T; Hayakawa T; Mizuguchi H
J Control Release; 2006 Jul; 113(3):271-8. PubMed ID: 16790289
[TBL] [Abstract][Full Text] [Related]
12. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
Pearson AS; Koch PE; Atkinson N; Xiong M; Finberg RW; Roth JA; Fang B
Clin Cancer Res; 1999 Dec; 5(12):4208-13. PubMed ID: 10632362
[TBL] [Abstract][Full Text] [Related]
13. Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.
Kanerva A; Mikheeva GV; Krasnykh V; Coolidge CJ; Lam JT; Mahasreshti PJ; Barker SD; Straughn M; Barnes MN; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2002 Jan; 8(1):275-80. PubMed ID: 11801569
[TBL] [Abstract][Full Text] [Related]
14. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.
Miller CR; Buchsbaum DJ; Reynolds PN; Douglas JT; Gillespie GY; Mayo MS; Raben D; Curiel DT
Cancer Res; 1998 Dec; 58(24):5738-48. PubMed ID: 9865732
[TBL] [Abstract][Full Text] [Related]
15. Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer.
Toivonen R; Suominen E; Grenman R; Savontaus M
Oncol Rep; 2009 Jan; 21(1):165-71. PubMed ID: 19082458
[TBL] [Abstract][Full Text] [Related]
16. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
17. Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway.
Tsuruta Y; Pereboeva L; Glasgow JN; Luongo CL; Komarova S; Kawakami Y; Curiel DT
Biochem Biophys Res Commun; 2005 Sep; 335(1):205-14. PubMed ID: 16061208
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
[TBL] [Abstract][Full Text] [Related]
19. Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells.
Zhong Z; Shi S; Han J; Zhang Z; Sun X
Mol Pharm; 2010 Feb; 7(1):105-15. PubMed ID: 19968324
[TBL] [Abstract][Full Text] [Related]
20. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
